Targeting the resolution pathway of inflammation using Ac2–26 peptide-loaded PEGylated lipid nanoparticles for the remission of rheumatoid arthritis

Rheumatoid arthritis (RA) is a common autoimmune disease characterized by joint inflammation and immune dysfunction. Although various therapeutic approaches have been utilized for the treatment of RA in clinical applications, the low responsiveness of RA patients and undesired systemic toxicity are...

Descripción completa

Detalles Bibliográficos
Autores principales: Qin, Xianyan, He, Liming, Fan, Donghao, Liang, Wenlang, Wang, Qin, Fang, Jiyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shenyang Pharmaceutical University 2021
Materias:
Original Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520054/
https://www.ncbi.nlm.nih.gov/pubmed/34703497
http://dx.doi.org/10.1016/j.ajps.2021.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8520054/
https://www.ncbi.nlm.nih.gov/pubmed/34703497
http://dx.doi.org/10.1016/j.ajps.2021.03.001

Ejemplares similares